McIlrath & Eck’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $174K | Buy |
353
+56
| +19% | +$30.4K | 0.01% | 278 |
|
|
2025
Q4 | $172K | Buy |
297
+100
| +51% | +$56.5K | 0.02% | 181 |
|
|
2025
Q3 | $95.5K | Hold |
197
| – | – | 0.01% | 220 |
|
|
2025
Q2 | $79.9K | Hold |
197
| – | – | 0.01% | 237 |
|
|
2025
Q1 | $98K | Hold |
197
| – | – | 0.01% | 205 |
|
|
2024
Q4 | $102K | Hold |
197
| – | – | 0.01% | 190 |
|
|
2024
Q3 | $122K | Sell |
197
-40
| -17% | -$23.7K | 0.02% | 166 |
|
|
2024
Q2 | $131K | Hold |
237
| – | – | 0.02% | 147 |
|
|
2024
Q1 | $138K | Hold |
237
| – | – | 0.02% | 142 |
|
|
2023
Q4 | $126K | Sell |
237
-11
| -4% | -$5.32K | 0.02% | 145 |
|
|
2023
Q3 | $126K | Hold |
248
| – | – | 0.03% | 144 |
|
|
2023
Q2 | $129K | Sell |
248
-1
| -0.4% | -$540 | 0.03% | 140 |
|
|
2023
Q1 | $144K | Buy |
249
+1
| +0.4% | +$564 | 0.03% | 127 |
|
|
2022
Q4 | $137K | Hold |
248
| – | – | 0.04% | 123 |
|
|
2022
Q3 | $126K | Buy |
248
+150
| +153% | +$83.9K | 0.03% | 122 |
|
|
2022
Q2 | $53K | Sell |
98
-51
| -34% | -$28.1K | 0.02% | 225 |
|
|
2022
Q1 | $88K | Hold |
149
| – | – | 0.03% | 160 |
|
|
2021
Q4 | $100K | Hold |
149
| – | – | 0.03% | 145 |
|
|
2021
Q3 | $85K | Hold |
149
| – | – | 0.03% | 164 |
|
|
2021
Q2 | $75K | Buy |
149
+92
| +161% | +$43.4K | 0.02% | 190 |
|
|
2021
Q1 | $26K | Buy |
57
+6
| +12% | +$2.86K | 0.01% | 303 |
|
|
2020
Q4 | $24K | Sell |
51
-4
| -7% | -$1.88K | 0.01% | 277 |
|
|
2020
Q3 | $24K | Hold |
55
| – | – | 0.01% | 232 |
|
|
2020
Q2 | $20K | Hold |
55
| – | – | 0.01% | 243 |
|
|
2020
Q1 | $16K | Hold |
55
| – | – | 0.01% | 234 |
|
|
2019
Q4 | $18K | Hold |
55
| – | – | 0.01% | 261 |
|
|
2019
Q3 | $16K | Hold |
55
| – | – | 0.01% | 257 |
|
|
2019
Q2 | $15K | Hold |
55
| – | – | 0.01% | 252 |
|
|
2019
Q1 | $15K | Sell |
55
-28
| -34% | -$6.97K | 0.01% | 252 |
|
|
2018
Q4 | $19K | Hold |
83
| – | – | 0.01% | 196 |
|
|
2018
Q3 | $20K | Hold |
83
| – | – | 0.01% | 211 |
|
|
2018
Q2 | $17K | Buy |
83
+28
| +51% | +$5.94K | 0.01% | 229 |
|
|
2018
Q1 | $11K | Buy |
55
+23
| +72% | +$4.83K | 0.01% | 253 |
|
|
2017
Q4 | $6K | Buy |
+32
| New | +$6.13K | ﹤0.01% | 348 |
|
Other funds holding TMO
VCM
McIlrath & Eck's TMO Position: Q1 2026 in Review
McIlrath & Eck increased its Thermo Fisher Scientific (TMO) stake by 19% in Q1 2026, buying an estimated $30.4K and bringing the position to 353 shares worth $174K. The position accounts for 0.01% of the portfolio, ranked #278.
McIlrath & Eck first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- McIlrath & Eck held 353 shares of Thermo Fisher Scientific worth $174K as of Q1 2026.
- McIlrath & Eck bought 56 Thermo Fisher Scientific shares in Q1 2026, an estimated $30.4K.
- Thermo Fisher Scientific made up 0.01% of McIlrath & Eck's portfolio in Q1 2026, its #278 holding.
- McIlrath & Eck first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.